First Mercantile Trust’s Pacific Biosciences PACB Stock Holding History

First Mercantile Trust’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21,320	Closed	-$115K	–	938
2018 Q3	$115K	Sell	21,320 -1,320	-6%	-$5.66K	0.02%	674
2018 Q2	$80K	Sell	22,640 -830	-4%	-$2.3K	0.02%	757
2018 Q1	$48K	Buy	23,470 +11,400	+94%	+$29.6K	0.01%	739
2017 Q4	$32K	Sell	12,070 -1,974	-14%	-$6.91K	0.01%	797
2017 Q3	$74K	Sell	14,044 -232	-2%	-$997	0.01%	745
2017 Q2	$51K	Buy	+14,276	New	+$57.6K	0.01%	788

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Mercantile Trust's PACB Position: Q4 2018 in Review

First Mercantile Trust sold out of Pacific Biosciences (PACB) in Q4 2018, closing a stake of 21,320 shares — an estimated $115K sold.

First Mercantile Trust first reported a position in PACB in Q2 2017 and held it in 6 quarters. The position peaked at $115K in Q3 2018. 155 funds tracked by Wall St. Rank hold PACB as of Q4 2018.

First Mercantile Trust reported no remaining Pacific Biosciences position as of Q4 2018 after selling out during the quarter.
First Mercantile Trust sold 21,320 Pacific Biosciences shares in Q4 2018, an estimated $115K.
First Mercantile Trust first reported a position in Pacific Biosciences in Q2 2017 and held it in 6 quarters.
First Mercantile Trust's Pacific Biosciences position peaked at $115K in Q3 2018.
155 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2018.

Based on First Mercantile Trust's 13F filing for Q4 2018, filed 1 Feb 2019.